PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
This Quarter Return
+31.62%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$19.1B
AUM Growth
+$19.1B
(+16%)
Cap. Flow
-$459M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
32.59%
Holding
317
New
27
Increased
96
Reduced
114
Closed
36
Top Buys
| 1 |
Vertiv
VRT
|
$245M |
| 2 |
Advanced Micro Devices
AMD
|
$201M |
| 3 |
Broadcom
AVGO
|
$178M |
| 4 |
Seagate
STX
|
$158M |
| 5 |
Lumentum
LITE
|
$141M |
Top Sells
| 1 |
Alibaba
BABA
|
$162M |
| 2 |
CyberArk
CYBR
|
$143M |
| 3 |
Meta Platforms (Facebook)
META
|
$129M |
| 4 |
Elastic
ESTC
|
$124M |
| 5 |
Corning
GLW
|
$87.7M |
Sector Composition
| 1 | Technology | 46.54% |
| 2 | Financials | 18.05% |
| 3 | Healthcare | 13.07% |
| 4 | Communication Services | 10.56% |
| 5 | Consumer Discretionary | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Vertex Pharmaceuticals
VRTX
$100B
| $39M | 0.2% | 87,500 -37,500 | -30% | -$16.7M |
|
102
Intercontinental Exchange
ICE
$101B
| $38.7M | 0.2% | 210,693 -53,602 | -20% | -$9.83M |
|
103
RLI Corp
RLI
$6.22B
| $38.6M | 0.2% | 535,000 +15,000 | +3% | +$1.08M |
|
104
Regeneron Pharmaceuticals
REGN
$61.5B
| $36.8M | 0.19% | 70,000 +15,000 | +27% | +$7.88M |
|
105
Globant
GLOB
$2.96B
| $36.5M | 0.19% | 402,226 +22,488 | +6% | +$2.04M |
|
106
Merit Medical Systems
MMSI
$5.36B
| $35.8M | 0.19% | 383,272 +575 | +0.2% | +$53.8K |
|
|
AVDL
107
Avadel Pharmaceuticals
AVDL
$1.43B
| $35.4M | 0.19% | 3,999,338 -356,626 | -8% | -$3.16M |
|
108
JPMorgan Chase
JPM
$829B
| $35M | 0.18% | 120,852 -103,155 | -46% | -$29.9M |
|
109
MakeMyTrip
MMYT
$9.4B
| $34.8M | 0.18% | 355,472 -450,395 | -56% | -$44.1M |
|
110
Affirm
AFRM
$28.8B
| $32.9M | 0.17% | 476,160 +418,432 | +725% | +$28.9M |
|
111
Integer Holdings
ITGR
$3.78B
| $32.4M | 0.17% | 263,673 -8,763 | -3% | -$1.08M |
|
112
Interactive Brokers
IBKR
$27.7B
| $31.8M | 0.17% | 574,476 +439,430 | +325% | +$24.3M |
|
113
Supernus Pharmaceuticals
SUPN
$2.53B
| $31.6M | 0.17% | 1,002,340 -360,000 | -26% | -$11.3M |
|
114
Mastercard
MA
$538B
| $30.7M | 0.16% | 54,682 -59,146 | -52% | -$33.2M |
|
115
Booking.com
BKNG
$181B
| $30.4M | 0.16% | 5,248 +70 | +1% | +$405K |
|
116
Fidelity National Information Services
FIS
$36.5B
| $30M | 0.16% | 368,649 -86,933 | -19% | -$7.08M |
|
117
UnitedHealth
UNH
$281B
| $29M | 0.15% | 92,842 -36,384 | -28% | -$11.4M |
|
118
US Foods
USFD
$17.5B
| $28.8M | 0.15% | 373,464 +117,230 | +46% | +$9.03M |
|
119
CG Oncology
CGON
$2.04B
| $28.6M | 0.15% | 1,098,662 +55,802 | +5% | +$1.45M |
|
120
BBB Foods
TBBB
$3.09B
| $28.2M | 0.15% | 1,016,034 -65,057 | -6% | -$1.81M |
|
121
Revolution Medicines
RVMD
$7.1B
| $27.7M | 0.14% | 751,655 +990 | +0.1% | +$36.4K |
|
122
Vaxcyte
PCVX
$4B
| $26.8M | 0.14% | 825,795 -256,678 | -24% | -$8.34M |
|
123
Walmart
WMT
$774B
| $25.5M | 0.13% | 260,650 +6,900 | +3% | +$675K |
|
124
Celldex Therapeutics
CLDX
$1.47B
| $25M | 0.13% | 1,228,435 -175,000 | -12% | -$3.56M |
|
125
89bio
ETNB
$1.34B
| $24.3M | 0.13% | 2,475,000 -25,000 | -1% | -$246K |
|